Reaction
Hodgkin'S Disease reporting signals
As of the last recalculation, Hodgkin'S Disease appears in 726 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 83.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 29 | 83.8 | 84.0 |
| Ritonavir 100 Mg | 14 | 27.4 | 27.4 |
| Infliximab | 163 | 27.3 | 27.3 |
| Lopinavir And Ritonavir | 12 | 25.8 | 25.8 |
| Ritonavir | 24 | 24.3 | 24.3 |
| Brentuximab Vedotin | 8 | 22.6 | 22.6 |
| Atazanavir | 10 | 20.2 | 20.2 |
| Darunavir | 9 | 17.3 | 17.3 |
| Efavirenz | 6 | 15.5 | 15.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 16 | 10.3 | 10.3 |
| Tenofovir Disoproxil Fumarate | 11 | 9.7 | 9.7 |